Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Oral Colchicine Combined With Intravitreal Infusion of Dexamethasone, LMW Heparin and 5-FU for Management of Proliferative Vitreoretinopathy (PVR)
This study is currently recruiting participants.
Study NCT00370760 Information provided by Shaheed Beheshti Medical University
First Received: August 30, 2006 Last Updated: June 25, 2008
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Proliferative Vitreoretinopathy
Additional conditions recognized in this trial
Vitreoretinopathy, Proliferative
More general conditions related to this trial
Eye Diseases
Retinal Diseases
Interventions listed in this trial
placebo
Additional drug interventions recognized in this trial
Colchicine
Dexamethasone
Dexamethasone acetate
Heparin
Heparin, Low-Molecular-Weight
More general drug interventions related to this trial
Anti-Inflammatory Agents
Anticoagulants
Antiemetics
Antimitotic Agents
Antineoplastic Agents
Antineoplastic Agents, Hormonal
Antirheumatic Agents
Autonomic Agents
Cardiovascular Agents
Central Nervous System Agents
Fibrin Modulating Agents
Fibrinolytic Agents
Gastrointestinal Agents
Glucocorticoids
Gout Suppressants
Hematologic Agents
Hormones
Hormones, Hormone Substitutes, and Hormone Antagonists
Mitosis Modulators
Molecular Mechanisms of Pharmacological Action
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Therapeutic Uses
Tubulin Modulators
Sponsors listed in this trial
Shaheed Beheshti Medical University
Back to top of Main Content
